Jaurretche Sebastián, Antogiovanni Norberto, Perretta Fernando
Centro de Neurociencias los Manantiales, Grupo Gamma, GINEF (Grupo de Investigación Nefrológica en la Enfermedad de Fabry), Rosario, Provincia de Santa Fe, Argentina.
Centro de Infusión y Estudio de Enfermedades Lisosomales del Instituto de Nefrología Clínica Pergamino, Argentina and GINEF (Grupo de Investigación Nefrológica en la Enfermedad de Fabry), Provincia de Buenos Aires, Argentina.
Mol Genet Metab Rep. 2017 May 23;12:41-43. doi: 10.1016/j.ymgmr.2017.05.007. eCollection 2017 Sep.
Nephropathy is one of the major complications of Fabry Disease (FD) and mainly includes reduced glomerular filtration rate (GFR) and proteinuria. Despite the frequency, scarce information exists regarding the frequency of CKD as well as other related complications in FD patients in Argentina. The aim of the study was to measure the prevalence of CKD at diagnosis of FD as well as to describe other related conditions in a large cohort of patients with FD. : a cross-sectional study performed in three FD centers of Argentina during January 2014 and January 2016. Information at diagnosis regarding patient demographics, disease characteristics, key laboratory values, and renal, cardiac, cerebrovascular diseases and other related complications were collected. A total of 60 patients were included. The mean age at diagnosis was 25.5 ± 16 years. 42% of included patients presented CKD in which the disease was mild (GFR ≥ 60 and < 90) in 60% ( = 15), moderate (GFR ≥ 30 and < 60) in 16% ( = 4), severe (GFR ≥ 15 and < 30) in 4% ( = 1) and failure (GFR < 15) in 20% ( = 5). Arrhythmias were reported for 13.3% of patients. In 33.3% the echocardiographic evaluation demonstrated left ventricular hypertrophy and peripheral neuropathy in 63.3%. : This study presents information regarding the prevalence of CKD in a large cohort of FD patients at the moment of diagnosis in Argentina. Future studies will help us to confirm these initial findings.
肾病是法布里病(FD)的主要并发症之一,主要包括肾小球滤过率(GFR)降低和蛋白尿。尽管发病率较高,但关于阿根廷FD患者慢性肾脏病(CKD)的发病率以及其他相关并发症的信息却很少。本研究的目的是测量FD诊断时CKD的患病率,并描述一大群FD患者的其他相关情况。:这是一项横断面研究,于2014年1月至2016年1月在阿根廷的三个FD中心进行。收集了诊断时有关患者人口统计学、疾病特征、关键实验室值以及肾、心、脑血管疾病和其他相关并发症的信息。共纳入60例患者。诊断时的平均年龄为25.5±16岁。纳入患者中有42%患有CKD,其中60%(n = 15)为轻度疾病(GFR≥60且<90),16%(n = 4)为中度(GFR≥30且<60),4%(n = 1)为重度(GFR≥15且<30),20%(n = 5)为肾衰竭(GFR<15)。13.3%的患者报告有心律失常。33.3%的患者经超声心动图评估显示有左心室肥厚,63.3%有周围神经病变。:本研究提供了关于阿根廷一大群FD患者诊断时CKD患病率的信息。未来的研究将有助于我们证实这些初步发现。